Spain Begins the Process of Medical Cannabis Legalization

The Ministry of Health in Spain has started the process of drafting a royal decree aimed at legalizing the use of cannabis for medical purposes.

For more news like this, along with all the latest in legalization, research, and lifestyle, download our free cannabis news app.

Spain Emphasizes Patient Safety and Product Quality

As highlighted in the draft decree, the text will prioritize patient safety and product quality. Spain aims to establish legal frameworks for standardized cannabis preparations proven to relieve pain and suffering, favoring oral administration—thus oils—for optimal therapeutic efficacy and safety.

Furthermore, the regulatory framework is designed to evolve dynamically, taking into account new knowledge and experiences gained from ongoing research and patient outcomes, both in Spain and internationally.

Civic Engagement in the Regulatory Process

Active involvement of civil society is a notable aspect of the regulatory process. Spanish citizens have the opportunity to contribute their views and ideas to the drafting process via an open public consultation on the ministry’s website.

Medical associations, palliative care societies, pain management specialists, and various other stakeholders in Spain have expressed their approval, highlighting the broad consensus on the need for comprehensive regulation of medical cannabis in Spain.

Spain Is Reflecting International Trends

The move towards medical cannabis regulation by Spain reflects developments in other European countries and international bodies. Countries such as Portugal, Germany, and Norway have already established regulatory frameworks for medical cannabis, acknowledging its therapeutic potential.

Moreover, endorsement beyond Spanish borders by global health authorities such as the World Health Organization and the United Nations confirms the legitimacy of these regulatory efforts.

—

(Featured image by Leo Korman via Unsplash)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.